[1]
“Retrospective evaluation of insulin degludec/insulin aspart co-formulation therapy in patients with type 2 Diabetes Mellitus: A single-center experience ”, Ann Med Res , vol. 27, no. 7, pp. 1961–1965, May 2021, Accessed: Apr. 04, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/855